stockrow
Friday 6 November 2026
Export ACH’s income statement to Excel — free account
Accendra Health, Inc.
ACH Healthcare Medical Distribution
Accendra Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 3.06% from fiscal 2024.
- Revenue
- −10.1%
- EPS
- +89.7%
- Free cash flow
- −1,624.8%
- Total debt
- −13.1%
Quarter to June 2026, against a year earlier
0.21
0.09
−30.00%
Follow ACH
Alert me
Accendra Health, Inc. (ACH) P/E ratio
Accendra Health, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 98.7× (March 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 63.2× | 343.31% |
| FY2021 | 14.3× | (79.44%) |
| FY2020 | 69.4× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 16.0× | (21.94%) |
| FY2016 | 20.5× | (5.95%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 98.7×
Ten-year median
0.0×
Current reading's percentile
51
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ACH Accendra Health, Inc. | n/m |
| FOCL FocalTherics compare | n/m |
| MEDS DataMeds AI, Inc compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| SNYRQ Synergy CHC Corp. compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| HSIC Henry Schein, Inc. compare | 22.8× |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)